¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"compl"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • complement-fixing antibody
    º¸Ã¼°áÇÕÇ×ü, µµ¿òü°áÇÕÇ×ü
  • complement-induced
    º¸Ã¼À¯µµ-
  • complement-mediated
    º¸Ã¼¸Å°³-
  • complement-mediated cytotoxicity
    º¸Ã¼¸Å°³¼¼Æ÷µ¶¼º
  • complemental tooth
    º¸ÃæÄ¡
  • complementarity
    »óº¸¼º
  • complementarity determining region
    »óº¸°áÁ¤ºÎÀ§
  • complementary afterimage
    º¸»öÀÜ»ó
  • complementary and alternative medicine
    º¸Ãæ´ë¾ÈÀÇÇÐ, º¸¿Ï´ëüÀÇÇÐ
  • complementary color
    º¸»ö
  • complementary factor
    º¸ÃæÀÎÀÚ
  • complementary feeding
    º¸Ã濵¾ç
  • complementary gene
    º¸Á·À¯ÀüÀÚ, »óÈ£º¸ÃæÀ¯ÀüÀÚ
  • complementary medicine
    º¸¿ÏÀÇÇÐ
  • complementary pair
    º¸Ã¼Â¦
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • complement receptor
    µµ¿òü¼ö¿ëü, º¸Ã¼¼ö¿ëü
  • complement splitting
    µµ¿òüºÐ¿­, º¸Ã¼ºÐ¿­
  • complement system
    µµ¿òü°èÅë, º¸Ã¼°èÅë
  • complement typing
    º¸Ã¼Çüº°°Ë»ç
  • complement-dependent cytotoxicity
    µµ¿òüÀÇÁ¸¼¼Æ÷µ¶¼º
  • complement-fixing antibody
    µµ¿òü°áÇÕÇ×ü, º¸Ã¼°áÇÕÇ×ü
  • complement-induced
    (¢¡complement-mediated) µµ¿òü¸Å°³-
  • complement-mediated
    µµ¿òü¸Å°³-
  • complement-mediated cytotoxicity
    µµ¿òü°ü·Ã¼¼Æ÷µ¶¼º
  • complemental tooth
    º¸ÃæÄ¡
  • complementarity
    »óº¸¼º, º¸Ã¼¼º, µµ¿òü¼º
  • complementarity determining region
    »óº¸¼º°áÁ¤ºÎÀ§
  • complementary
    º¸Á·-, º¸Ã¼-, µµ¿òü-
  • complementary afterimage
    º¸»öÀÜ»ó
  • complementary color
    º¸»ö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • complement dependent cytotoxicity
    º¸Ã¼ÀÇÁ¸¼º ¼¼Æ÷µ¶¼º
  • complement fixation =CF
    º¸Ã¼°íÁ¤(¡­Í³ïÒ).
  • complement fixation =CF
    º¸Ã¼°áÇÕ(¡­Ì¿ùê).
  • complement fixation inhibition test
    º¸Ã¼°íÁ¤ÀúÇØ½ÃÇè(ÜÍô÷ͳïÒîÁúªãËúÐ).
  • complement fixation inhibition test
    º¸Ã¼°áÇÕÀúÇØ½ÃÇè(ÜÍô÷Ì¿ùêîÁúªãËúÐ).
  • complement fixation reaction
    º¸Ã¼°áÇÕ¹ÝÀÀ(¡­Úãëë).
  • complement fixation test
    º¸Ã¼°áÇÕ½ÃÇè
  • complement fixation test =CFT
    º¸Ã¼°íÁ¤½ÃÇè(¡­ãËúÐ).
  • complement fixation test =CFT
    º¸Ã¼°áÇÕ½ÃÇè(¡­ãËúÐ).
  • complement fixation test, indirect
    °£Á¢º¸Ã¼°áÇÕ½ÃÇè
  • complement fixation unit =CF unit
    º¸Ã¼°áÇÕ´ÜÀ§(¡­Ó¤êÈ).
  • complement fixing antibody
    º¸Ã¼°áÇÕÇ×ü(¡­ù÷ô÷).
  • complement fixing neutralization antibody
    º¸Ã¼°áÇÕ¼º ÁßÈ­Ç×ü.
  • complement inhibitor
    º¸Ã¼ÀúÁöÀÎÀÚ.
  • complement inhibitor
    º¸Ã¼ÀúÁöÀÎÀÚ.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • complementation
    »óº¸(ßÓÜÍ)
  • complementation group
    »óº¸±º(ßÓÜÍÏØ)
  • complementation map
    »óº¸Áöµµ(ßÓÜÍò¢Óñ)
  • complementation test
    »óº¸½ÃÇè(ßÓÜÍãËúÐ)
  • complete antibody
    ¿ÏÀüÇ×ü(èÇîïù÷ô÷)
  • complete antigen
    ¿ÏÀüÇ׿ø(èÇîïù÷ê«)
  • complete medium
    ¿ÏÀü¹èÁö(èÇîïÛÆò¢)
  • complete oxidation
    ¿ÏÀü»êÈ­(èÇîïß«ûù)
  • complete protein
    ¿ÏÀü´Ü¹éÁú(èÇîïÓ±ÛÜòõ)
  • complete transduction
    ¿ÏÀüÇüÁúµµÀÔ(èÇîïû¡òõÓôìý)
  • complete virion
    ¿ÏÀü(èÇîï)ºñ¸®¿Â
  • complex
    º¹ÇÕ¹°(ÜÜùêÚª)
  • complex glycoproteins
    º¹ÇÕ ´ç´Ü¹éÁú(ÜÜùêÓØÓ±ÛÜòõ)
  • complex hapten
    º¹ÇÕ(ÜÜùê) ÇÕÅÙ
  • complex ion
    º¹ÇÕ(ÜÜùê) ÀÌ¿Â
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • JrId: 26947
    JournalTitle: completely annotated. Rhode Island.
    MedAbbr: Gen Laws R I 1956 R I
    ISSN:
    ESSN:
    IsoAbbr:
    NlmId: 101135769
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • O04.5
    Complete or unspecified, complicated by genital tract and pelvic infection
    »ý½Ä·Î ¹× °ñ¹Ý°¨¿°¿¡ ÀÇÇØ ÇÕº´µÈ ¿ÏÀü ¶Ç´Â »ó¼¼ºÒ¸íÀÇ À¯»ê
  • O05.5
    Complete or unspecified, complicated by genital tract and pelvic infection
    »ý½Ä·Î ¹× °ñ¹Ý°¨¿°¿¡ ÀÇÇØ ÇÕº´µÈ ¿ÏÀü ¶Ç´Â »ó¼¼ºÒ¸íÀÇ À¯»ê
  • O06.5
    Complete or unspecified, complicated by genital tract and pelvic infection
    »ý½Ä·Î ¹× °ñ¹Ý°¨¿°¿¡ ÀÇÇØ ÇÕº´µÈ ¿ÏÀü ¶Ç´Â »ó¼¼ºÒ¸íÀÇ À¯»ê
  • O03.8
    Complete or unspecified, with other and unspecified complications
    ±âŸ ¹× »ó¼¼ºÒ¸íÀÇ ÇÕº´ÁõÀÌ µ¿¹ÝµÈ ¿ÏÀü ¶Ç´Â »ó¼¼ºÒ¸íÀÇ À¯»ê
  • O04.8
    Complete or unspecified, with other and unspecified complications
    ±âŸ ¹× »ó¼¼ºÒ¸íÀÇ ÇÕº´ÁõÀÌ µ¿¹ÝµÈ ¿ÏÀü ¶Ç´Â »ó¼¼ºÒ¸íÀÇ À¯»ê
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • complete amputation
    ¿ÏÀü Àý´Ü
  • complete aphasia
    ¿ÏÀü ½Ç¾îÁõ
    ¸ðµç ¾ð¾î ÁßÃßÀÇ º´º¯¿¡ ÀÇÇÑ ½Ç¾îÁõ. ¾î¶°ÇÑ ¹æ¹ýÀ¸·Îµµ ŸÀΰú Àǻ縦 ¼ÒÅëÇÒ ¼ö ¾ø°Ô µÇ´Â °Í.
  • complete bed rest
    ¿ÏÀü »ó ¾ÈÁ¤
  • complete blood count
    ÀüÇ÷ °Ë»ç, ÀüÇ÷±¸ °è»ê
  • complete cleft of lip
    ¿ÏÀü ±¸¼ø ÆÄ¿­
  • complete crown
    ÀüºÎ °ü
    ÀÓ»óÀû Ä¡°üÀÇ ÇØºÎÇÐÀûÀÎ ¿ä¼Ò¸¦ ÀΰøÀû ´ë¿ë¹°À» ÀÌ¿ëÇÏ¿© ¿øÇü´ë·Î ¼öº¹ÇÑ º¸Ã¶¹°·Î, Çü¼ºµÈ Áö´ëÄ¡¿¡ ÀåÂøµÇ¾î ÀûÇյǾî Áø´Ù.
  • complete denture prosthetics
    ÃÑÀÇÄ¡ º¸Ã¶ÇÐ
  • complete disinfectant
    ¿ÏÀü ¼Òµ¶¾à
  • complete dissociation
    ¿ÏÀü ÇØ¸®
  • complete facial moulage
    Àü¾È¸ð Àλó
  • complete fracture
    ¿ÏÀü °ñÀý
  • complete hemispherectomy
    ¿ÏÀü ´ë³ú ¹Ý±¸ ÀýÁ¦¼ú
  • complete impacted tooth
    ¿ÏÀü ¸Åº¹Ä¡
  • complete lingual crossbite
    ¿ÏÀü ¼³Ãø ¹Ý´ë±³ÇÕ
  • complete prosthesis
    ÃÑÀÇÄ¡
    ¹«Ä¡¾Ç¿¡ ÀçÇÑ ÀΰøÀû ȸº¹¹°.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
complement 3d <chemical> An inactivated fragment of complement 3b (c3b). Factor h makes c3b susceptible to factor I (formerly called kaf, c3binf, or enzyme 3b inactivator) to form ic3b. Then factor I and a trypsin-like proteolytic enzyme further cleave ic3b into c3c and c3dg. Serum proteases degrade c3dg into complement 3d (c3d) and c3g.
Chemical name: Complement C3d
(12 Dec 1998)
complement 4 The second component to react in the complement sequence. It is a beta-globulin with a sedimentation coefficient of 18.7, a molecular weight of 240,000 and a serum concentration of 430 micrograms/ml. It is activated by complement 1 and serves as a receptor for c2.
(12 Dec 1998)
complement 4a <chemical> Smaller fragment formed when c1s splits c4 into c4a and c4b. As an anaphylatoxin, c4a causes symptoms of immediate hypersensitivity but it has weaker activity than c3a or c5a.
Chemical name: Complement C4a
(12 Dec 1998)
complement 4b <chemical> Larger fragment formed when c1s splits c4 into c4a and c4b. C4b combines with c2b to form the activated c4b2b complex which is often called the classical pathway c3 convertase.
Chemical name: Complement C4b
(12 Dec 1998)
complement 5 The fifth component in the complement reaction sequence, probably exists in a complex with c6 and c7. It is a beta-globulin with a sedimentation coefficient of 10, serum concentration of 75 micrograms/ml and molecular weight of 180,000. It is activated by c423 and releases fragments with anaphylatoxic, chemotactic, and histamine-releasing actions and affecting smooth muscle.
(12 Dec 1998)
complement 5a <chemical> Smaller fragment formed when c5 convertase splits c5 into c5a and c5b. C5a is a 74-amino acid peptide that includes a carboxy-terminal arginine crucial for its spasmogenic activity and a carbohydrate moiety. C5a is the most potent anaphylatoxin mediating immediate hypersensitivity.
Chemical name: Complement C5a
(12 Dec 1998)
complement 5a, des-arginine Complement 5a with the carboxy-terminal arginine removed. The arginine is rapidly cleaved from the c5a fragment during complement activation by carboxypeptidase b present in normal human serum. C5a des-arg shows complete loss of spasmogenic activity though it retains some chemotactic ability.
(12 Dec 1998)
complement 6 The sixth component in the complement reaction sequence. It is a beta-globulin with a sedimentation coefficient of 8.7 and a molecular weight of 120,000 at 60 micrograms/ml in serum. It may exist in a complex with c5 and c7 and is activated by the binding of c5.
(12 Dec 1998)
complement 7 The seventh component in the complement reaction sequence. It is a beta-globulin probably in a complex with c5 and c6 and is activated by c5. The attachment of c7 renders the cell susceptible to lysis.
(12 Dec 1998)
complement 8 The next to the last essential component for cell lysis in the complement reaction sequence. It is a gamma-globulin with a molecular weight of 150,000 and a sedimentation coefficient of 8. It is present in trace amounts in serum and can be inhibited, like complement 1, by cation chelators.
(12 Dec 1998)
complement 9 The last component in the complement reaction sequence. It is an alpha-globulin present in serum as a trace, with a molecular weight of 80,000 and a sedimentation coefficient of 4.5. For cell lysis, it can be replaced by a metal chelator.
(12 Dec 1998)
complement activating enzymes <enzyme> Enzymes present in the complement system which activate one or more components in the system.
Registry number: EC 3.-
(12 Dec 1998)
complement activation The sequential activation of serum components c1 through c9, initiated by an erythrocyte-antibody complex or by microbial polysaccharides and properdin, and producing an inflammatory response.
(12 Dec 1998)
complement binding assay A test for the detection of immune complexes.
(05 Mar 2000)
complement chemotactic factor The activated complex of the fifth, sixth, and seventh components of complement (C567) which induces chemotaxis in the case of polymorphonuclear leukocytes.
(05 Mar 2000)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 2
  • Complement C1q - »õâ A subcomponent of complement C1, composed of six copies of three polypeptide chains (A, B, and C), each encoded by a separate gene (C1QA; C1QB; C1QC). This complex is arranged in nine subunits (six disulfide-linked dimers of A and B, and three disulfide-linked homodimers of C). C1q has binding sites for antibodies (the heavy chain of IMMUNOGLOBULIN G or IMMUNOGLOBULIN M). The interaction of C1q and immunoglobulin activates the two proenzymes COMPLEMENT C1R and COMPLEMENT C1S, thus initiating the cascade of COMPLEMENT ACTIVATION via the CLASSICAL COMPLEMENT PATHWAY.
    Synonyms : C1q Complement, Complement 1q, Complement Component 1q, C1q, Complement, Complement, C1q, Component 1q, Complement
  • Complement C1r - »õâ A 80-kDa subcomponent of complement C1, existing as a SERINE PROTEASE proenzyme in the intact complement C1 complex. When COMPLEMENT C1Q is bound to antibodies, the changed tertiary structure causes autolytic activation of complement C1r which is cleaved into two chains, A (heavy) and B (light, the serine protease), connected by disulfide bonds. The activated C1r serine protease, in turn, activates COMPLEMENT C1S proenzyme by cleaving the Arg426-Ile427 bond. No fragment is released when either C1r or C1s is cleaved.
    Synonyms : C1r Complement, Complement 1r, Complement Component 1r, C1r, Complement, Complement, C1r, Component 1r, Complement
  • Complement C1s - »õâ A 77-kDa subcomponent of complement C1, encoded by gene C1S, is a SERINE PROTEASE existing as a proenzyme (homodimer) in the intact complement C1 complex. Upon the binding of COMPLEMENT C1Q to antibodies, the activated COMPLEMENT C1R cleaves C1s into two chains, A (heavy) and B (light, the serine protease), linked by disulfide bonds yielding the active C1s. The activated C1s, in turn, cleaves COMPLEMENT C2 and COMPLEMENT C4 to form C4b2a (CLASSICAL C3 CONVERTASE).
    Synonyms : C 1 Esterase, C1 Esterase, C1s Complement, Complement 1 Esterase, Complement 1s, Complement Component 1s, C1s, Complement, Complement, C1s, Component 1s, Complement, Esterase, C 1, Esterase, C1, Esterase, Complement 1
  • Complement C2 - »õâ A component of the CLASSICAL COMPLEMENT PATHWAY. C2 is cleaved by activated COMPLEMENT C1S into COMPLEMENT C2B and COMPLEMENT C2A. C2a, the COOH-terminal fragment containing a SERINE PROTEASE, combines with COMPLEMENT C4B to form C4b2a (CLASSICAL PATHWAY C3 CONVERTASE) and subsequent C4b2a3b (CLASSICAL PATHWAY C5 CONVERTASE).
    Synonyms : C2 Complement, Complement 2, Complement Component 2, C2, Complement, Complement, C2, Component 2, Complement
  • Complement C2a - »õâ The COOH-terminal fragment of COMPLEMENT 2, released by the action of activated COMPLEMENT C1S. It is a SERINE PROTEASE. C2a combines with COMPLEMENT C4B to form C4b2a (CLASSICAL PATHWAY C3 CONVERTASE) and subsequent C4b2a3b (CLASSICAL PATHWAY C5 CONVERTASE).
    Synonyms : C2a Complement, Complement 2a, Complement C2 Fragment a, Complement C2a Fragment, C2a Fragment, Complement, C2a, Complement, Complement, C2a
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 2 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 10 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
complete blood count counting the number of white and red blood cells and the number of platelets in 1 cubic millimeter of blood
Ãâó: wordnet.princeton.edu/perl/webwn
complex absence petit mal seizure accompanied by other abnormalities (atonia or automatisms or vasomotor changes)
Ãâó: wordnet.princeton.edu/perl/webwn
complementary of words or propositions so related that each is the negation of the other; "`male' and `female' are complementary terms" complementary color: either one of two chromatic colors that when mixed together give white (in the case of lights) or grey (in the case of pigments); "yellow and blue are complementaries" complemental: acting as or providing a complement (something that completes the whole)
Ãâó: wordnet.princeton.edu/perl/webwn
complementary DNA single-stranded DNA that is complementary to messenger RNA or DNA that has been synthesized from messenger RNA by reverse transcriptase
Ãâó: wordnet.princeton.edu/perl/webwn
complete fracture break involving the entire width of the bone
Ãâó: wordnet.princeton.edu/perl/webwn
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • complaisant
    °ø¼ÕÇÑ; Á¤ÁßÇÑ
  • complaisant
    °ø¼ÕÇÑ;Á¤ÁßÇÑ;À¯¼øÇÑ;°íºÐ°íºÐÇÑ;~ly
  • complanate
    µ¿ÀÏ Æò¸é¿¡ ³õÀÎ;ÆíÆòÇØÁø
  • complanation
    Æò¸éÈ­;°î¸é ±¸Àû¹ý 
  • compleat
    =COMPLETE
  • complect
    ÇÔ²² ¿«´Ù;¼¯¾î Â¥´Ù
  • complected
    ¼¯¾î§;º¹ÀâÇÑ;¾È»öÀÌ ...ÇÑ
  • complement
    º¸ÃæÇÏ¿© ¿ÏÀüÇÏ°Ô ÇÏ´Â °Í
  • complement
    º¸ÃæÇÏ¿© ¿ÏÀüÇÏ°Ô ÇÏ´Â °Í;º¸¿Ï¹°;¿©¼ö;¿©°¢;¿©È£;º¸ÃæÀ½Á¤;(ÇÊ¿äÇÑ)Àü¼ö;Àü·®;½Â¹«¿ø Á¤¿ø;º¸ÃæÇÏ¿© ¿ÏÀüÄÉÇÏ´Ù;º¸¿Ï(º¸Ãæ)ÇÏ´Ù;...ÀÇ º¸¿ÏÀÌ µÇ´Ù
  • complement fixation
    º¸Ã¼ °áÇÕ
  • complemental
    =COMPLEMENTARY;~ly
  • complementary
    º¸ÃæÀûÀÎ
  • complementary
    º¸¿ÏÀûÀÎ;¼­·Î º¸¿ÏÇÏ´Â;º¸»ö;-tarily
  • complementary angle
    ¿©°¢
  • complementary cell
    º¸Á· ¼¼Æ÷
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
compl an expression of grievance or resentment
compl (formerly) a loud cry (or repeated cries) of pain or rage or sorrow
compl an often persistent bodily disorder or disease
compl expressing pain or dissatisfaction of resentment
compl a disposition or tendency to yield to the will of others
compl showing a cheerful willingness to do favors for others
compl be interwoven or interconnected
compl something added to complete or make perfect
compl either of two parts that mutually complete each other
compl a word or phrase used to complete a grammatical construction
compl number needed to make up whole force
compl a complete number or quantity
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 2
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á